Clinical evaluation of sirupillaigal perukka nei for pharyngitis.

A Clinical evaluation of sirupillaigal perukka nhei for valikanam(pharyngitis)in children. - vali kanam

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2016/06/007021

Enrollment

Registered

2016-06-13

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- patients with symptoms of cough,fever,lack of appetite,sore throat

Interventions

Intervention1: SIRUPILLAIGAL PERUKKA NEI: SIRUPILLAIGAL PERUKKA NEI is a polyherbal formulation 1 KARANDI(4 ml) 3-7 years (bid) dose oral route 7 days duration Control Intervention1: NA: NA

Eligibility

Inclusion criteria

Inclusion criteria: patients with symptoms of cough,fever,lack of appetite,sore throat

Exclusion criteria

Exclusion criteria: H/O active primary complex H/O pneumonia H/O severe asthma H/O enteric fever or long term fever

Design outcomes

Primary

Measure	Time frame
Number and screening of clinical symptoms are slightly reduced such as cough,sore throat etc...Timepoint: clinical symptoms reduced	—

Secondary

Measure	Time frame
clinical efficacy of the trial drug and its side effects if any..Timepoint: the experimental drug may have good efficacy and safety in clinical study	—

Countries

India

Contacts

Public ContactDrPArul mozhi

National institute of siddha

kalyas53@gmail.com9444946270

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026